Cited by 167Multiple Sclerosis Research StudiesPolyomavirus and related diseasesPeripheral Neuropathies and Disorders

Primary P rogressive M ultiple S clerosis E volving F rom R adiologically I solated S yndrome

Open access
Kantarci, Orhun H., Lebrun, Christine, Siva, Aksel, Keegan, Mark B., Azevedo, Christina J., Inglese, Matilde, Tintoré, Mar, Newton, Braeden D. +6 more·2016·Annals of Neurology

Abstract

Objective: The aim of this work was to evaluate the preprogressive phase in subjects with radiologically isolated syndrome (RIS) who evolve to primary progressive multiple sclerosis (PPMS). Methods: A multicenter RIS cohort was previously established. Demographic, clinical, and radiological characteristics of subjects with RIS that evolved directly to PPMS were compared to those that developed a relapsing disease course from onset (clinically isolated syndrome [CIS] or relapsing‐remitting MS) and were also compared to two other population‐ and clinic‐based PPMS cohorts. Results: Of the 453 subjects with RIS, 128 evolved to symptomatic MS during the follow‐up (113 developed a first acute clinical event consistent with CIS/MS, 15 evolved to PPMS). PPMS prevalence (11.7%) and onset age (mean ± standard deviation; 49.1 ± 12.1) in the RIS group were comparable to other PPMS populations (p > 0.05). Median time to PPMS was 3.5 years (range, 1.6–5.4). RIS evolved to PPMS more commonly in men (p = 0.005) and at an older age (p < 0.001) when compared to CIS/MS, independent of follow‐up duration. Subjects who evolved to PPMS had more spinal cord lesions (100%) before symptomatic evolution than those that developed CIS/MS (64%) and those that remained asymptomatic (23%) within the follow‐up period (P = 0.005). Other MRI characteristics in the preprogressive phase of PPMS were indistinguishable from CIS/MS. Interpretation: Subjects with RIS evolve to PPMS at the same frequency as expected from general MS populations in an age‐dependent manner. Besides age, unequivocal presence of spinal cord lesions and being male predicted evolution to PPMS. Our findings further suggest that RIS is biologically part of the MS spectrum. Ann Neurol 2016;79:288–294

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.24564

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Factors predicting increased risk of subsequent MS diagnosis in RIS are similar to those predicting MS diagnosis after a CIS: younger age, higher cerebral lesion load, asymptomatic infratentorial or spinal cord lesions, gadolinium-enhancing lesions, presence of CSF OCBs, and abnormal VEP.

    “The factors predicting increased risk of subsequent MS diagnosis are similar to those predicting MS diagnosis after a CIS: younger age, higher cerebral lesion load, asymptomatic infratentorial or spinal cord lesions, gadolinium-enhancing lesions, presence of CSF OCBs, and abnormal VEP. 87,89”

    From Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria (2018) · cites this paper as [89]

    The supplied passages are a repository listing for the paper, not its study text; the file listing labels the manuscript as a post-print but gives no findings. Searches for RIS conversion risk factors, lesion load, oligoclonal bands, and abnormal visual evoked potentials returned only title and author information. Our available copy therefore does not establish whether the paper supports the claimed predictors or their similarity to predictors after CIS. (LLM, conf=0.74)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kantarci, O. H., Lebrun, C., Siva, A., Keegan, M. B., Azevedo, C. J., Inglese, M., Tintoré, M., Newton, B. D., Durand‐Dubief, F., Amato, M. P., De Stefano, N., Sormani, M. P., Pelletier, D., & Okuda, D. T.
Affiliations
  • Mayo Clinic (US)
  • Hôpital Pasteur, Service de Neurologie Nice France
  • Department of Neurology Cerrahpasa School of Medicine, University of Istanbul Istanbul Turkey
  • University of Southern California (US)
  • Icahn School of Medicine at Mount Sinai (US)
  • Vall d'Hebron Hospital Universitari (ES)
  • The University of Texas Southwestern Medical Center (US)
  • Service de Neurologie, Hôpital Neurologique Bron France
  • University of Florence (IT)
  • Department of Neurology Neurosurgery and Behavioral Sciences, University of Siena Siena Italy
  • University of Genoa (IT)
Corresponding author
Kantarci, Orhun H.
Venue
Annals of Neurology
Publisher
Wiley
Published
2015-12-29
Volume
79
Issue
2
Pages
288-294
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2173194334
Cited by
167
References
1
Citations by year
2026: 10 · 2025: 11 · 2024: 15 · 2023: 16 · 2022: 11 · 2021: 18 · 2020: 16 · 2019: 14 · 2018: 29 · 2017: 16 · 2016: 11
FWCI
14.83
Type
journal article
Language
en
Open access
Locations
  • Annals of Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • Florence Research (University of Florence) (submittedVersion)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
  • Use Siena air (University of Siena) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
  • Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
  • Health Sciences › Medicine › Neurology › Peripheral Neuropathies and Disorders
Keywords
primary progressive multiple sclerosis, radiologically isolated syndrome, disease progression, spinal cord lesions, clinically isolated syndrome, relapsing-remitting multiple sclerosis, MRI lesions, age of onset, sex differences
MeSH terms
Adolescent, Adult, Age Factors, Child, Demyelinating Diseases, Female, Follow-Up Studies, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Sex Factors, Disease Progression, Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Relapsing-Remitting, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review